Medtronic’s Cardiac Disease Management Offerings Seek To Grow HF Market

Medtronic believes that its foray into cardiac disease management with the Chronicle implantable hemodynamic monitor will differentiate its devices from competitors Guidant and St. Jude

More from Archive

More from Medtech Insight